C4 Therapeutics (CCCC) Total Non-Current Liabilities (2020)

C4 Therapeutics (CCCC) posted quarterly Total Non-Current Liabilities of $123.1 million for Q3 2020.

C4 Therapeutics (CCCC) Total Non-Current Liabilities (2020) Analysis & Trends

C4 Therapeutics' Total Non-Current Liabilities history runs 1 years deep, the most recent figure standing at $123.1 million for Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Non-Current Liabilities (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	5.92 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	7.74 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	40.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	1.53 Bn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	1.88 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	9.32 Bn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	4.20 Bn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	1.17 Bn
10	C4 Therapeutics	521.12 Mn	267.46 Mn	-	-

Download Data

Date	Value
Sep 30, 2020	123.07 Mn